
Vencia 37.5mg Tablet
Marketer
A N Pharmacia Laboratories Pvt Ltd
Salt Composition
Venlafaxine (37.5mg)
Overview Vencia 37.5mg Tablet
Deprexan 37.5mg tablets treat depressive and anxiety disorders by modifying brain chemistry responsible for anxiety symptoms like agitation, hyperactivity, poor focus, tiredness, perspiration, rapid heartbeat, and racing thoughts. Consume Deprexan 37.5mg with food at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon recollection; avoid skipping doses and complete the prescribed course, even with symptom improvement. Abrupt cessation is inadvisable due to potential symptom exacerbation. Common side effects include queasiness, vomiting, sleep disturbances, reduced appetite, nervousness, bowel irregularity, increased perspiration, and sexual difficulties. Drowsiness and dizziness may occur; avoid driving or mentally demanding tasks until the medication's effects are known. These side effects are generally transient and self-limiting. Consult your physician if they persist or are bothersome. Prior to commencing Deprexan 37.5mg, disclose any kidney, heart, liver issues, or seizure history. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your doctor.
Primary Ingredients of Vencia 37.5mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vencia 37.5mg Tablet
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Vencia 37.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vencia 37.5mg Tablets should be administered with a meal.
Common Side effects of Vencia 37.5mg Tablet:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Vencia 37.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vencia 37.5mg Tablet should be administered with a meal.
How Vencia 37.5mg Tablet works:
Vencia 37.5mg tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vencia 37.5mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vencia 37.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Vencia 37.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Close observation of newborns for drowsiness and satisfactory weight increase is recommended.
DrivingUNSAFE
Driving ability may be impaired by Vencia 37.5mg Tablet side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving performance.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Vencia 37.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Vencia 37.5mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Vencia 37.5mg Tablet :
Should you forget to take your Vencia 37.5mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vencia 37.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
